Table 2 Impact of Coronavirus disease 2019 (COVID-19) pandemic on neurosurgery activity and facilities, education and research

From: Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis

Variable Number of hospitals (%)
Annual neurosurgery volume (median [IQR]) 400 [350; 700]
Number of neurosurgery beds (median [IQR]) 63 [45; 116]
Reduction in neurosurgery case volume due to COVID-19
  < 25% 20 (13.9)
 26–50% 56 (38.9)
 51–75% 42 (29.2)
 76–100% 26 (18.1)
Reduction in number of dedicated neurosurgery ORs
 Little to no reduction 66 (45.8)
 Small reduction (< 1/3 of neurosurgery ORs) 6 (4.2)
 Moderate reduction (< 2/3 of neurosurgery ORs) 13 (9.0)
 Major reduction (≥ 2/3 of neurosurgery ORs) 19 (13.2)
 No dedicated ORs (100% reduction of neurosurgery ORs) 9 (6.3)
Reduction in number of neurosurgery ICU beds
 Little to no reduction 93 (64.6)
 Small reduction (< 1/3 of total ICU beds) 8 (5.6)
 Moderate reduction (< 2/3 of total ICU beds) 11 (7.6)
 Major reduction (≥ 2/3 of total ICU beds) 15 (10.4)
 No dedicated ICU beds (100% reduction of ICU beds) 9 (6.3)
Current number of ventilators (median [IQR]) 9 [4; 20]
Number of hospitals with increased ventilators 42 (29.2)
 Percentage increase in number of ventilators (median) 0.5%
Level of personal protection by neurosurgeons operating on COVID-19-negative patients
 Routine gowning 73 (50.7)
 Routine gowning with N95 mask 35 (24.3)
 Gowns with junctions sealed, with air supply or self-contained breathing apparatus 21 (14.6)
 Completely enclosed gowns with self-contained breathing apparatus 15 (10.4)
Scheduled neurosurgeries still being performed as planned on COVID-19 positive patients 34 (23.4)
At the peak of the pandemic, was there shortage of COVID-19 related supplies/PPE in the hospital?
 Little or no disruption 40 (27.8)
 Moderate disruption 71 (49.3)
 Severe disruption 20 (13.9)
Level of personal protection by neurosurgeons operating on COVID-19-positive patients
 Routine gowning 14 (9.7)
 Routine gowning with N95 mask 17 (11.8)
 Gowns with junctions sealed, with air supply or self-contained breathing apparatus 11 (7.6)
 Completely enclosed gowns with self-contained breathing apparatus 101 (70.1)
Changes to pre-operative COVID-19 screening guidelines for CNS tumor patients 120 (83.3)
If yes, what changes?
 Confirmation of COVID-19 status by laboratory test as negative 58 (48.4)
 Screening for COVID-19 based on history, clinical manifestation, and imaging 62 (51.6)
Suspension of post-operative adjuvant therapy 52 (36.1)
If no, what measures have been taken to administer post-operative adjuvant therapy?
 Home-based assisted treatment 4 (2.8)
 Strict isolation, single room treatment 14 (9.7)
 Intensive screening for COVID-19 29 (20.1)
 Improving the protection level of doctors and patients 12 (8.3)
 Referral to other hospitals 35 (24.3)
Staff training to operate ventilators? 93 (64.6)
Number of neurosurgeons/fellows per hospital (median [IQR]) 16 (9; 30)
Personnel relocation from neurosurgery to other departments 91 (63.2)
Relocation of:
 Neurosurgeons 68 (47.2)
 Operating room nurses/technicians 35 (24.3)
 Trainees 75 (52.1)
 ICU nurses 91 (63.2)
 Floor nurses 91 (63.2)
Routine continuation of research 21 (14.6)
Suspension of research 85 (59.0)
Modifications of research 31 (21.5)
 Research personnel working from home 14 (9.7)
 Clinical research continuing but basic science research suspended 3 (2.1)
 Segregation of research personnel 14 (9.7)
Trainees permitted to perform cases 67 (46.5)
Trainees required to stay at home unless on call or critically needed 78 (54.2)
Medical students mandated to stay at home 104 (72.2)
  1. CNS central nervous system, ICU intensive care unit, IQR inter-quartile range, OR operating room, SD standard deviation